|
 |
| |
 |
|
|
|
|
 |
| Management Team |
|
|
Jean-Jacques Bienaimé |
|
Steven Jungles |
| Chief Executive Officer |
|
Vice President,
Supply Chain |
Jeffrey H. Cooper |
|
Daniel P. Maher |
Senior Vice President,
Chief Financial Officer |
|
Vice President,
Product Development |
Emil D. Kakkis, M.D., Ph.D. |
|
Charles A. O'Neill, Ph.D. |
Senior Vice President,
Chief Medical Officer |
|
Vice President,
Pharmacological Sciences |
Jeff Ajer |
|
R. Andrew Ramelmeier |
Vice President,
Sales and Marketing Operations |
|
Vice President,
Manufacturing and Process Development |
Stephen Aselage |
|
Victoria Sluzky, Ph.D. |
Senior Vice President,
Global Commercial Development |
|
Vice President,
Quality and Analytical Chemistry |
Robert A. Baffi, Ph.D. |
|
Stuart J. Swiedler, M.D., Ph.D. |
Senior Vice President,
Technical Operations |
|
Senior Vice President,
Clinical Affairs |
Luisa Bigornia |
|
Gordon Vehar, Ph. D. |
Vice President,
Intellectual Property |
|
Vice President,
Research |
Lewis Chapman |
|
Amy Waterhouse |
Vice President,
Global Marketing |
|
Vice President,
Regulatory and Government Affairs |
G. Eric Davis |
|
Mark Wood |
Vice President,
General Counsel and Secretary |
|
Vice President,
Human Resources |
Steve Glass |
|
|
Vice President,
General Manager, European Operations |
|
|
|
|
|
|
| Board of Directors
|
|
|
Jean-Jacques Bienaimé |
|
Pierre Lapalme |
| Chief Executive Officer |
|
Former President
and Chief Executive Officer,
North America Ethypharm, Inc. |
Michael Grey |
|
V. Bryan Lawlis |
President and
Chief Executive Officer,
SGX Pharmaceuticals, Inc. |
|
President & Chief Executive Officer,
Itero Biopharmaceuticals, Inc. |
Elaine Heron |
|
Alan Lewis |
Chairman and
Chief Executive Officer,
Labcyte Inc. |
|
President
and Chief Executive Officer,
Novocell, Inc. |
Joseph Klein, III |
|
Randy Meier |
Managing Director,
Gauss Capital Advisors, LLC. |
|
Executive Vice President of
Operations, President of
Global Eye Care,
and Chief Financial Officer,
Advanced Medical Optics |
|
|
|
|
|
|
| Science
Advisory Board |
Jeffrey Borer, M.D. |
Director, The Howard Gilman Institute for Valvular Heart Diseases
Weill Medical College of Cornell University
New York, New York
|
Raymond C. Stevens, Ph.D. |
Professor of Molecular Biology & Chemistry
The Scripps Research Institute
La Jolla, California |
Robert Langer, Sc.D. |
Professor of Toxicology and BEH
Massachusetts Institute of Technology
Cambridge, Massachusetts |
Alan J. Lewis, Ph.D. |
President and Chief Executive Officer
Novocell, Inc.
San Diego, California |
Joseph Loscalzo, M.D., Ph.D. |
Chairman, Department of Medicine
Brigham and Women's Hospital
Boston, Massachusetts
Editor in Chief, Circulation |
David L. Rimoin, M.D., Ph.D. |
Steven Spielberg Chair and Director, Medical Genetics Institute
Director, International Skeletal Dysplasia Registry
Cedar-Sinai Medical Center
Los Angeles, California
|
Larry J. Shapiro, M.D. |
Spencer T. and Ann W. Olin Distinguished Professor
Executive Vice Chancellor for Medical Affairs and Dean
Washington University School of Medicine
St. Louis, Missouri |
John Urquhart, M.D. |
Chief Scientist
AARDEX Ltd.
Zug, Switzerland |
|
|
|
|
|
|
